Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus

Cytokine

Volumn 49, Issue 1, 2010, Pages 51-57

  Kopp, Andrea ^a   Bala, Margarita ^a   Weigert, Johanna ^a   Büchler, Christa ^a   Neumeier, Markus ^a   Aslanidis, Charalampos ^a   Schölmerich, Jürgen ^a   Schäffler, Andreas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

CTRP 3; Monocyte; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; CHOLESTEROL; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q TUMOR NECROSIS FACTOR RELATED PROTEIN 3; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STIMULATION; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INSECT CELL; LIPOPROTEIN METABOLISM; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; UPREGULATION;

ADIPONECTIN; ADULT; AGED; ANIMALS; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS; YOUNG ADULT;

HEXAPODA;

EID: 71649096763     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.10.001     Document Type: Article

References (28)

1. Schaffler A., Muller-Ladner U., Scholmerich J., and Buchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 27 (2006) 449-467
2. Schaffler A., Scholmerich J., and Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28 (2007) 393-399
3. Shapiro L., and Scherer P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8 (1998) 335-338
4. Wong G.W., Wang J., Hug C., Tsao T.S., and Lodish H.F. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 101 (2004) 10302-10307
5. Schaffler A., Ehling A., Neumann E., Herfarth H., Paul G., Tarner I., et al. Genomic organization, promoter, amino acid sequence, chromosomal localization, and expression of the human gene for CORS-26 (collagenous repeat-containing sequence of 26-kDa protein). Biochim Biophys Acta 1630 (2003) 123-129
6. Schaffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Gay S., et al. Genomic organization, chromosomal localization and adipocytic expression of the murine gene for CORS-26 (collagenous repeat-containing sequence of 26 kDa protein). Biochim Biophys Acta 1628 (2003) 64-70
7. Schaffler A., Ehling A., Neumann E., Herfarth H., Paul G., Tarner I., et al. Role of specificity protein-1, PPARgamma, and pituitary protein transcription factor-1 in transcriptional regulation of the murine CORS-26 promoter. Biochim Biophys Acta 1678 (2004) 150-156
8. Schaffler A., Weigert J., Neumeier M., Scholmerich J., and Buechler C. Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin". Obesity (Silver Spring) 15 (2007) 303-313
9. Maeda T., Abe M., Kurisu K., Jikko A., and Furukawa S. Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem 276 (2001) 3628-3634
10. Weigert J., Neumeier M., Schaffler A., Fleck M., Scholmerich J., Schutz C., et al. The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells. FEBS Lett 579 (2005) 5565-5570
11. Maeda T., Jikko A., Abe M., Yokohama-Tamaki T., Akiyama H., Furukawa S., et al. Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes. J Cell Physiol 206 (2006) 537-544
12. Akiyama H., Furukawa S., Wakisaka S., and Maeda T. Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways. FEBS J 273 (2006) 2257-2263
13. Akiyama H., Furukawa S., Wakisaka S., and Maeda T. CTRP3/cartducin promotes proliferation and migration of endothelial cells. Mol Cell Biochem 304 (2007) 243-248
14. Flegel W.A., Wolpl A., Mannel D.N., and Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 57 (1989) 2237-2245
15. Stogbauer F., Neumeier M., Weigert J., Wanninger J., Grandl M., Lehle K., et al. Highly efficient and low-cost method to isolate human blood monocytes with high purity. J Immunol Methods 337 (2008) 78-80
16. Wurm S, Neumeier M, Weigert J, Schaffler A, Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol 2007;6:7.
17. Neumeier M., Weigert J., Schaffler A., Wehrwein G., Muller-Ladner U., Scholmerich J., et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 79 (2006) 803-808
18. Santos-Alvarez J., Goberna R., and Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194 (1999) 6-11
19. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 (2007) 1748-1758
20. Lehrke M., and Lazar M.A. Inflamed about obesity. Nat Med 10 (2004) 126-127
21. Hancu N., Netea M.G., and Baciu I. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom J Physiol 35 (1998) 325-330
22. Gupta A., Ten S., and Anhalt H. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18 (2005) 75-82
23. Hamilton T.A., Ma G.P., and Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J Immunol 144 (1990) 2343-2350
24. Zykova S.N., Svartberg J., Seljelid R., Iversen H., Lund A., Svistounov D.N., et al. Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apolipoprotein B in patients with type 2 diabetes. Scand J Immunol 60 (2004) 535-542
25. Pajkrt D., Doran J.E., Koster F., Lerch P.G., Arnet B., van der Poll T., et al. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184 (1996) 1601-1608
26. Thompson P.A., and Kitchens R.L. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol 177 (2006) 4880-4887
27. Chen C.H., Lee R.P., Wu W.T., Liao K.W., Hsu N., and Hsu B.G. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats. Resuscitation 74 (2007) 166-174
28. Okopien B., Krysiak R., Kowalski J., Madej A., Belowski D., Zielinski M., et al. Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates. J Cardiovasc Pharmacol 46 (2005) 377-386